- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.08. | Conexeu Sciences Inc.: Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration | 1 | GlobeNewswire (USA) | ||
| 14.07. | Conexeu Sciences Inc.: The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It | 1 | GlobeNewswire (USA) | ||
| 09.07. | One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics | 4 | CNW | ||
| 07.07. | Conexeu Sciences Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| CONEXEU SCIENCES Aktie jetzt für 0€ handeln | |||||
| 07.07. | Conexeu Sciences Inc.: A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today's Injectables Were Not Built to Fill | 1 | GlobeNewswire (USA) | ||
| 25.06. | Conexeu Sciences Inc.: Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform | 1 | GlobeNewswire (USA) | ||
| 22.06. | Conexeu Sciences stock initiated at buy by H.C. Wainwright, $20 target | 1 | Investing.com | ||
| 15.06. | Conexeu Sciences Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 15.06. | Conexeu Sciences Inc.: Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing | 251 | GlobeNewswire (Europe) | RENO, Nev., June 15, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company"), a biotechnology company advancing tissue regeneration, today announced additions to... ► Artikel lesen | |
| 09.06. | Conexeu Sciences Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.06. | Conexeu Sciences: Aktie legt nach Fortschritten bei Wundversorgungs-Produkt zu | 1 | Investing.com Deutsch | ||
| 08.06. | Conexeu forciert Produktionsaufbau für Wundpflege-Produkt vor geplantem FDA-Antrag 2027 | - | Investing.com Deutsch | ||
| 08.06. | Conexeu Sciences Inc.: Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU Wound Care Program | 1 | GlobeNewswire (USA) | ||
| 03.06. | Conexeu Sciences Inc.: Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026 | 1 | GlobeNewswire (USA) | ||
| 21.05. | Conexeu Sciences Inc.: Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU" | 534 | Newsfile | Reno, Nevada--(Newsfile Corp. - May 21, 2026) - Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company"), a biotechnology company advancing tissue regeneration, announced it has officially... ► Artikel lesen | |
| 19.05. | Conexeu Sciences Inc.: Conexeu Sciences Advances 3D Biofabricated Matrix to Move Breast Reconstruction Beyond Implants | 513 | Newsfile | Conexeu's B.R.E.A.S.T. was developed using the Company's proprietary CXU regenerative tissue platform to support gradual tissue remodelingDesigned as a resorbable, bioregenerative tissue matrix... ► Artikel lesen | |
| 14.05. | Conexeu Sciences Inc.: Conexeu Sciences Unveils Defining Commitment: Architecting Bioregeneration | 494 | Newsfile | Reno, Nevada--(Newsfile Corp. - May 14, 2026) - Conexeu Sciences Inc. (the "Company" or "Conexeu") a medical device company advancing regenerative medicine through its patented bioregenerative extracellular... ► Artikel lesen | |
| 12.05. | Medical device developer Conexeu Sciences set to direct list on the Nasdaq on May 21 | 1 | Renaissance Capital | ||
| 11.05. | Conexeu Sciences Inc. - 8-A12B, Registration of securities | - | SEC Filings | ||
| 17.04. | Conexeu Sciences Inc. - S-1/A, General form for registration of securities | - | SEC Filings |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CERENOME | 2,555 | -3,77 % | Cerenome, Inc.: Cerenome Reports Second Quarter 2026 Financial Results and Business Update | HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,220 | +0,83 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| CYTOSORBENTS | 0,288 | -0,69 % | Cytosorbents Corp: CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | Highlighting Four Independent Drivers of Shareholder Value
PRINCETON, N.J., Aug. 6, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,590 | -1,64 % | Clover Health Investments, Corp.: Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 | WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great... ► Artikel lesen | |
| FULGENT GENETICS | 16,900 | -0,59 % | Fulgent expects $330M-$340M 2026 revenue as billing transition lowers collection rates | ||
| EMBECTA | 4,390 | +0,62 % | Dividendenbekanntmachungen (27.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDTECH AB SE0014781795 3,6 SEK 0,3243 EUR ALLIANCE WITAN PLC GB00B11V7W98 0,0733 GBP 0,0855 EUR ATMUS FILTRATION TECHNOLOGIES... ► Artikel lesen | |
| CHECK-CAP | 5,350 | -3,60 % | Check-Cap Ltd. Announces Pricing of $10 Million Public Offering of Ordinary Shares | ISFIYA, Israel, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: MBAI), an embodied artificial intelligence company, announced today the pricing of its public... ► Artikel lesen | |
| ELECTROCORE | 8,500 | 0,00 % | electroCore, Inc.: electroCore's Truvaga Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards | ||
| CATHETER PRECISION | 0,203 | +0,25 % | Catheter Precision, Inc.: Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany | Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business Johns Hopkins Hospital, a world-renowned academic... ► Artikel lesen | |
| CLEARPOINT NEURO | 15,560 | +0,06 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Reports Second Quarter 2026 Results | Positive BioPharma Partner Regulatory Progress and Early Success in Focused Ultrasound Technology Platform Expansion SOLANA BEACH, CA / ACCESS Newswire / August 3, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT)... ► Artikel lesen | |
| ENVUE MEDICAL | 0,350 | +1,60 % | ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split | TYLER, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that a reverse stock split... ► Artikel lesen | |
| ENDRA LIFE SCIENCES | 5,250 | +4,90 % | ASP Isotopes Inc.: ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing | Combination, if successful, would establish Noble Africa as a Nasdaq-listed, helium platform for Renergen's Virginia Gas Project Listing expected to provide investors with direct exposure to one of... ► Artikel lesen | |
| FIREFLY NEUROSCIENCE | 1,080 | 0,00 % | Firefly Neuroscience, Inc.: Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes | KENMORE, N.Y., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company advancing precision neuroscience... ► Artikel lesen | |
| FEMASYS | 3,210 | +0,31 % | Femasys partners with UNC Health for fertility services | ||
| CUPRINA HOLDINGS | 3,010 | +0,33 % | Morning Market Movers: Cuprina Holdings, CEA Industries, Absci, The Wendy's Company See Big Swings | MEMPHIS (dpa-AFX) - At 7:10 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |
CONEXEU SCIENCES INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 7,060 Euro und damit -0,14 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CONEXEU SCIENCES INC finden Sie auf Wallstreet Online.